Last Updated : September 7, 2018
Details
FilesGeneric Name:
Peginterferon beta-1a
Project Status:
Complete
Therapeutic Area:
Multiple sclerosis, relapsing-remitting
Manufacturer:
Biogen Canada Inc.
Call for patient/clinician input open:
Brand Name:
Plegridy
Project Line:
Reimbursement Review
Project Number:
SR0440-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC
Performance Metric:
Achieved
Submission Type:
Initial
Indications:
Multiple Sclerosis, relapsing
Recommendation Type:
List with criteria/condition
Final Recommendation:
Files
Last Updated : September 7, 2018